Member Info for krull

They should be able to buy in our market any time it's open, as long as they are not in bed/sleeping

Oxford BioDynamics has participated in more than 40 partnerships with big pharma and leading institutions including Pfizer, EMD Serono, Genentech, Roche, Biogen, Mayo Clinic, Massachusetts General Hospital and Mitsubishi Tanabe Pharma.

The Company has created a valuable technology portfolio, including biomarker arrays, molecular diagnostic tests, bioinformatic tools for 3D genomics and an expertly curated 3D genome knowledgebase comprising hundreds of millions of data points from over 10,000 samples in more than 30 human diseases.

OBD is headquartered in Oxford, UK and is listed on AIM of the London Stock Exchange. It also has a commercial office in Gaithersburg and a clinical laboratory in Frederick, MD, USA, and a reference laboratory in Penang, Malaysia.

Anyone think there could be an RNS Monday morning

Yes, the momentum has turned downwards for now, it's the traders leaving, they will be replaced by investors which will turn it back the other way at some point, just a matter of when

Yes Tricky, that's the difference between an investor and a trader, an investor thinks about the potential possibility's, where's a trader just looks at the share price or chart

Ohh dear davey50, that logic would apply when it was 50% up then 100% then 150% and so on, how gutted would you have been cashing out only 50% up!!! You clearly don't understand the potential pointed out to you in the RNS

Yes 404X, with a bit of tweaking this technology is very likely to be able to detect over types of cancers!!!

That overlap is humongous, could turn this tiddler in a whale.

Yes, the chunky trades are buys for sure.

Bline59, No negativity is directed to at you from what I can make out

No one likes to talk about how much they own, It's considered vulgar

Are you shorting, please share also, what percentage is it of ur total wealth??

LOL. an uninformed troll taking up residence

Along with other blood tests, I get my prostate tested once a year in my annual check up

400/500m market cap is more realistic in my opinion

The dips are being bought in seconds, still big demand for stock out there

I'm in, this is going to be snapped up by a big pharma for big money.

Yes bandit1, suppose my thoughts on where to place my stop could be called a strategy, I was thinking, 45 to buy would be a holding ground, after that, then 40 would need to held.

You are quite right, AIM is manipulated, that is my opinion as well. I did weigh that up and thought it could well be the case. But also thought the M-cap is not that small for an AIM stock and would not be easy to be manipulated. I did also think, what ever I do, it will be the wrong decision.

That's me done, my stop loss has been taken out, took about a 20% hit, it's been going down too fast for my liking, I fear something is wrong.

Now that I'm out, it will most likely go back up! I may buy back if the price settles with out any concern turning up.

Good luck guys.

It's typical for shares to drift lower after news, but they soon get snapped up if it drifts too far! plenty of news about new country distribution agreements are going to be in the pipe line for a while, hope this doesn't turn into a traders share

Yes, a market cap of £141m, does not look too big when you consider eroxon will eventually be sold world wide.